Seminal fluid interacts with the female reproductive tract to initiate a permissive immune response that facilitates embryo implantation and pregnancy success. The immune-regulatory cytokine interferon-γ (IFNG), which can be elevated in seminal plasma, is associated with reduced fertility. Here, we investigated how IFNG influences the female immune response to seminal fluid. In human Ect1 cervical epithelial cells, IFNG added at physiologically relevant concentrations substantially impaired seminal plasma-induced synthesis of key cytokines colony-stimulating factor 2 (CSF2) and interleukin-6 (IL6). Seminal fluid-induced CSF2 synthesis was also suppressed in the uterus of mice in vivo, when IFNG was delivered transcervically 12 h after mating. Transforming growth factor B1 (TGFB1) is the major seminal fluid signaling factor which elicits CSF2 induction, and IFNG exhibited potent dose-dependent suppression of CSF2 synthesis induced by TGFB1 in murine uterine epithelial cells in vitro. Similarly, IFNG suppressed TGFB1-mediated CSF2 induction in Ect1 cells and human primary cervical epithelial cells; however, IL6 regulation by IFNG was independent of TGFB1. Quantitative PCR confirmed that CSF2 regulation by IFNG in Ect1 cells occurs at the gene transcription level, secondary to IFNG suppression of TGFBR2 encoding TGFB receptor 2. Conversely, TGFB1 suppressed IFNG receptor 1 and 2 genes IFNGR1 and IFNGR2. These data identify IFNG as a potent inhibitor of the TGFB-mediated seminal fluid interaction with relevant reproductive tract epithelia in mice and human. These findings raise the prospect that IFNG in the male partner's seminal fluid impairs immune adaptation for pregnancy following coitus in women. 
Introduction
The immune environment at conception has a substantial influence on embryo implantation and progression of pregnancy [1] . In mice, humans, and many mammalian species, male seminal fluid plays an active role in regulating female reproductive tract gene expression and priming the immune response required for pregnancy [2, 3] . This is mediated by signaling agents in seminal fluid that interact with female tract epithelial cells to elicit synthesis of CSF2 (GM-CSF) and several other cytokines and chemokines including IL6 and chemokine (C-X-C motif) ligand 1 (CXCL1). CSF2 is a key regulator of the ensuing inflammationlike response, acting to modulate the phenotype of macrophages, dendritic cells, and neutrophils recruited into the cervix and endometrium [4, 5] . In turn, these immune cells prime regulatory T cells (Treg cells) to accumulate in the lymph nodes and decidua where they exert anti-inflammatory protection, suppress generation of destructive immunity to paternally derived transplantation antigens, and promote maternal vascular adaptation and robust placental development [6, 7] .
Studies in Csf2 null mutant mice demonstrate that CSF2 contributes to reproductive success through regulating uterine macrophages, dendritic cells, and the T cell response [5, 8, 9] . CSF2 induced at conception is secreted into the oviduct and uterine lumen to also promote blastocyst development, as demonstrated in mice, pig, and human [10] [11] [12] . Embryo development in the absence of CSF2 causes later perturbations in fetal and placental development and postnatal growth [13] . The consequences of an altered immune environment at conception extend beyond fertilization and embryo implantation to influence pregnancy progression. In mice, when conception occurs in the absence of seminal plasma (SP) contact, CSF2 is not induced and this compromises placental and fetal development, leading to altered postnatal growth and metabolic anomalies in offspring [14] . Similarly in pigs, embryo contact with CSF2 is required for normal epigenetic programming and optimal fetal growth and offspring health [15] .
In women, the postcoital immune response is initiated in the ectocervix [16] . Cervical tissue biopsies collected before and after intercourse show that seminal fluid induces expression of CSF2 and other cytokines, resulting in an inflammation-like infiltration of macrophages, dendritic cells, and lymphocytes [17] . Genes encoding CSF2, IL6, C-X-C motif chemokine ligand 8 (CXCL8, previously known as IL8) and C-C motif chemokine ligand 2 (CCL2, previously known as MCP1) are induced in cervical epithelial cells in vivo [17] . Changes in T cell markers are consistent with seminal fluid priming of the adaptive immune response in women, analogous to induction of Treg cells in mice [2] . Seminal fluid priming has consequences for fertility and reproductive success in women [2, 18] , such that prior sexual cohabitation with the conceiving partner confers protection from preeclampsia and in utero growth restriction [19] . In the assisted reproduction setting, conception rate is improved if coitus with the conceiving partner occurs around the time of embryo transfer [20, 21] .
The seminal fluid factors that signal to the female tract include the three isoforms of TGFB (TGFB1, TGFB2, and TGFB3), plus other TGFB family members and hydroxylated prostaglandin E (19-OH PGE1 and 19-OH PGE2) [22, 23] . There is variation in the content of these factors between men, and also within individual men over time [24] . In vitro experiments using primary ectocervical epithelial cells and immortalised Ect1 cells identify TGFB1, TGFB2, and TGFB3 as key mediators of CSF2 gene expression and protein secretion in women [22] as well as in mice [25] .
IFNG is another cytokine present in variable amounts in the seminal fluid of men [26] [27] [28] [29] . IFNG is a T cell cytokine usually made by T helper type 1 cells and natural killer cells during infection to drive cell-mediated immunity and pathogen clearance, but can also be induced by sterile proinflammatory agents [30, 31] . Although IFNG is generally low or undetectable in seminal fluid of fertile men [26] [27] [28] [29] , reproductive tract infection causes IFNG to be substantially elevated [32, 33] . IFNG is also moderately increased in SP of men with abnormal sperm parameters [26, 28] , and there is evidence of a similar increase in men with idiopathic infertility [34] and in couples with recurrent miscarriage [35] .
These observations raise the question of whether seminal fluid IFNG contributes to unexplained infertility in some couples through effects on the female immune response. Here, we test the hypothesis that IFNG can modify the initial phase of the female reproductive tract cytokine response to seminal fluid priming. Utilizing well-characterized in vitro models of seminal fluid signaling in human Ect1 cells and primary ectocervical epithelial cells, as well as in vivo and in vitro experiments in mice, we demonstrate that IFNG suppresses seminal fluid cytokine induction, particularly CSF2.
Materials and Methods

Mice and surgical treatments
All animal experiments were performed in accordance with the Guiding Principles for the Care and Use of Animals in Research, as endorsed by the Society for the Study of Reproduction, with ethical approval for this study provided by the University of Adelaide Ethics Committee (approval number M-61-04). Mice were housed in a specific pathogen-free facility at The University of Adelaide under a 12 h light-12 h dark cycle, with food and water available ad libitum. C57Bl/6 (B6) mice were purchased from the University of Adelaide Central Animal Facility. BALB/c stud males of proven fertility and up to 12 months of age were housed individually and used in all mating experiments. B6 females were caged with stud males and the morning of detection of a copulatory plug was day 0.5 postcoitum (pc). Estrous mice were identified by vaginal lavage cytology using phase contrast microscopy (Nikon TMS, Japan).
Recombinant cytokines
For both in vitro and in vivo mouse experiments, Escherichia coli-derived recombinant mouse IFNG and CHO cell-derived recombinant mouse TGFB1 were purchased from R&D Systems (485-MI and 7666-MB respectively; Minneapolis, USA). Escherichia coli lipopolysaccharide was from Sigma Aldrich (St. Louis, MO). For in vitro human experiments, CHO-derived recombinant human TGFB1 and E. coli-derived recombinant human IFNG were from R&D Systems (240-B and 285-IF respectively; Minneapolis, MN).
Murine uterine epithelial cell culture
Uteri were excised from estrous B6 mice, and epithelial cell cultures were prepared as previously described [36, 37] . Briefly, uteri were trimmed and slit length-wise, then incubated with 0.5% trypsin (Life Technologies) + 2.5% pancreatin (Merck) for 45 min at 4
• C followed by 45 min at 37
• C. An equal volume of RPMI-FCS
[RPMI-1640 supplemented with 5% or 10% fetal calf serum (FCS, Sigma Aldrich, Castle Hill, AU) as specified], 5 × 10 − 5 M β-mercaptoethanol, 2 mM L-glutamine, 60 μg/ml penicillin-G and 100 μg/ml streptomycin) was added, and uterine tissue was repeatedly extruded through a plastic transfer pipette to liberate epithelial cells which were pelleted at 400× g and washed in RPMI-FCS. Cell culture experiments with IFNG were conducted in the absence of penicillin-G (RPMI-FCS-P). Epithelial cells were resuspended at 4 × 10 5 cells/ml in RPMI-FCS or RPMI-FCS-P, and 100 or 500 μl aliquots were plated in 96-well or 4-well multidishes (Nunc, Roskilde, Denmark) as indicated. After 4 h at 37
• C in 5% CO2 to permit adherence, TGFB1 (0, 0.5, or 5 ng/ml) and IFNG (0, 0.03, 0.15, 0.6, 2.5, 10, or 40 ng/ml) were added alone or in combination, and cells were cultured for a further 16 h. Treatments were then removed and replaced with fresh media, which was collected 24 h later, centrifuged at 400× g and stored at -80
• C for later analysis of CSF2, IL6, and CXCL1 content. Adherent cells were quantified using Rose Bengal dye uptake as described previously [10, 38] . Treatments were evaluated in duplicate, and experiments were repeated three times, unless specified.
In vivo administration of IFNG IFNG (50 ng) was infused into the uterine cavity of mated B6 female mice by transcervical administration at 0900 h, on day 0.5 pc. An auroscope with pediatric attachment was inserted into the vagina to visualize the cervix, after removing the copulatory plug with forceps. The magnifier was removed and a rigid dilation catheter was inserted through the cervical opening. The dilation catheter was removed and treatments administered using a catheter with marked increments to displace 30 μl. Control groups included mated B6 females given carrier alone, or left untreated. Mice were killed 8 h post-treatment at 1700 h and uterine luminal fluid flushed from each horn in 500 μl RPMI-FCS was stored at -80
• C for later analysis of CSF2, IL6, and CXCL1. cells/well). After 5-7 days, media was replaced with 500 μl of fresh ECM/2% FCS. A "pre-treatment" supernatant was collected 12 h later and replaced with 500 μl of ECM/2% FCS containing combinations of TGFB1 and IFNG or culture media alone. After 12 h, the treatment was replaced with ECM/2% FCS, which in turn was collected 24 h later ("post-treatment"), centrifuged and stored at -80
• C for cytokine analysis.
Human Ect1 cervical epithelial cell culture
Ect1 cells were propagated as described [41, 42] in keratinocyte serum-free media (Gibco, Mount Waverley, Australia) supplemented with 0.1 ng/ml recombinant human epidermal growth factor (Gibco), 0.05 mg/ml bovine pituitary extract (Gibco) and 0.4 mM CaCl 2 (KSFM). For experiments, 1 × 10 5 cells in 500 μl of KSFM were seeded in 12-well culture plates (Nunc) and incubated at 37
• C/5% CO 2 for 2-3 days to generate a confluent monolayer, then medium was replaced with 500 μl of fresh KSFM. A "pretreatment" supernatant was collected 12 h later and replaced with 500 μl of KSFM containing combinations of TGFB1 and IFNG or culture media alone. For the SP spiking experiment, Ect1 cells were cultured to confluence before adding combinations of 10% SP (v/v) from each of three proven fertile individual men, and IFNG or culture media alone. Treatment was replaced with fresh KSFM (500 μl) at 12 h, which was collected 24 h later ("post-treatment") and stored at -80
• C for cytokine analysis. To evaluate cytokine, chemokine, and cytokine receptor mRNA expression, Ect1 cells were instead incubated with individual treatments for 8 h (37 • C/5% CO 2 ) then washed thoroughly with PBS before solubilization in 500 μl TRIzol (Life Technologies) for RNA extration. All treatments were evaluated in triplicate and experiments repeated three times.
Quantitative real-time PCR
Total cellular RNA was extracted from Ect1 cells or mouse uterine epithelial cells using TRIzol following treatment with RNase-free Turbo DNase I (500 IU/ml; 30 min/37
• C) (Roche, Basel, Switzerland). RNA quality was assessed by Agilent 2100 Bioanalyzer (Agilent Technologies, California, USA) before first-strand cDNA was 
reverse transcribed from 2 μg RNA employing a Superscript-IV Reverse Transcriptase kit. Quantitative PCR (qPCR) was performed on 20 ng of cDNA containing PCR primers (Table 1 ) and 1× Power SYBR Green PCR master mix (Life Technologies). Negative controls contained H 2 O substituted for cDNA or RNA without reverse transcription. PCR amplification was performed in a QuantStudio 3 Real-Time PCR System v1.2 (Life Technologies) using the following conditions: 50
• C for 2 min and 95
• C for 10 min followed by 40 cycles of 95
• C for 15 s and 60
• C for 1 min. The delta C(t) method [43] was used to calculate mRNA abundance normalized to ACTB mRNA expression. PCR products were analyzed by dissociation curve profile and product size confirmation by gel electrophoresis. PCR product (10 μl) was separated on a 2% agarose gel containing 1× GelRed TM (Biotium, Hayward, USA) next to a 1 kb plus DNA ladder (Life Technologies), then bands were excised and sequenced using Big Dye version 3 (Applied Biosystems) to confirm product identity.
Mouse and human ELISAs
CSF2, IL6, and CXCL1 (KC, the mouse homologue of IL8) in mouse uterine epithelial cell supernatants and in vivo luminal fluid samples were measured by ELISA (all R&D Systems, DY415, DY406, and DY453 respectively). Minimum detectable thresholds were 1.8 pg/ml (CSF2), 1.6 pg/ml (IL6), and 2.0 pg/ml (CXCL1), with intra-and interassay coefficients of variation all <10%. CSF2, IL6, and CXCL8 (IL8) were measured in human cell culture supernatants by ELISA (all R&D Systems, DY215, DY206, and DY208). Minimum detectable thresholds were 15.6 pg/ml (CSF2), 9.0 pg/ml (IL6), and 31.2 pg/ml (CXCL1), with intra-and interassay coefficients of variation all <5%. Samples were assayed in duplicate according to the manufacturers' instructions.
Statistics
Mouse cytokine data were analyzed using non-parametric KruskalWallis and Mann-Whitney U-test to evaluate differences between treatment groups, after evaluation by Shapiro-Wilk test showed data sets were not normally distributed. For primary ectocervical epithelial cell experiments, data were excluded when pretreatment supernatants from control and treatment wells deviated by >10%. Human cytokine data were analyzed by one-way ANOVA followed by Tukey's post hoc test for multiple comparisons to identify significant differences between treatment groups. Effects of IFNG and TGFB1 on cytokine receptor expression were evaluated by mixed model analysis. All analysis used SPSS version 22.0 (SPSS, Chicago, IL) or PRISM software version 7.02 for Windows (GraphPad Software, La Jolla California USA). Statistical significance between different treatment groups was inferred when P < 0.05.
Results
IFNG inhibits seminal fluid-induced cytokine synthesis in human Ect1 cells
Initially, we investigated whether human Ect1 ectocervical epithelial cells express mRNA encoding the two IFNG receptors, IFNGR1 and IFNGR2. Quantitative PCR of cDNA from untreated Ect1 cells showed robust expression of both IFNGR1 and IFNGR2 mRNAs (Supplemental Figure 1A) , indicating capacity to respond to IFNG. We then investigated whether the cytokine-inducing effects of human SP are altered by IFNG. Seminal plasma from each of three fertile men were used individually, after each were demonstrated to be clear of endogenous IFNG (<3 pg/ml). Ect1 cells were incubated with IFNG alone (0.05 or 5 ng/ml, reflecting low and high values within the range typically found in human SP [26] [27] [28] [29] ), 10% SP (SP1, SP2, or SP3), SP in combination with IFNG, or media alone. Each of the three SP samples induced CSF2 (mean increase of 9.7-fold; Figure 1A ), IL6 (10.4-fold; Figure 1B ), CXCL8 (5.9-fold; Figure 1C ) compared to controls (all P < 0.001), with some between-individual variability consistent with previous reports [22, 44] . Addition of exogenous IFNG caused dose-dependent suppression of the SP-induced cytokine response in Ect1 cells. CSF2 was most susceptible, with 5 ng/ml IFNG suppressing CSF2 production by 50%, 44%, and 69% for SP1 (P < 0.001), SP2 (P = 0.001), and SP3 (P < 0.001), respectively ( Figure 1A ). Even at the low concentration of 0.05 ng/ml, IFNG suppressed CSF2 output by 38% and 44% in two of three SP samples (SP1, P < 0.001 and SP3, P < 0.001, respectively).
IL6 was also suppressed by IFNG. With 5 ng/ml IFNG, IL6 induced by SP1 and SP3 was reduced by 70% (P < 0.001) and 64% (P < 0.001). With 0.05 ng/ml IFNG, IL6 was reduced by 47% and 52% for SP1 and SP3, respectively (both P < 0.001). In contrast, limited and variable effects of IFNG were seen for CXCL8. At 5 ng/ml, IFNG moderately reduced SP-induced CXCL8 in Ect1 cells, but only for SP1 (P = 0.023), and not SP2 or SP3 ( Figure 1C ). There was little change in Ect1 cell production of CSF2, IL6, or CXCL8 caused by IFNG alone (Figure 1A-C) .
IFNG suppresses the postmating cytokine response in mice in vivo
We next sought to examine whether IFNG can perturb seminal fluid signaling in vivo, in a mouse model. Female B6 mice were mated and values of triplicate wells for each of three experiments and mean ± SEM is shown. Effects of treatments were analyzed by one-way ANOVA followed by Tukey's post hoc test. * P < 0.05, * * P < 0.001 compared to media alone control; # P < 0.05, compared to SP without IFNG.
50 ng IFNG was instilled into the uterine cavity via transcervical catheter at 0900 h on day 0.5 pc, around 9 h after mating. This time point was chosen as removal of copulatory plugs to access the cervix was difficult prior to that. Control groups included mated mice given carrier alone or left untreated, and uterine luminal fluid was collected for cytokine analysis 8 h later. Mean uterine CSF2 content was reduced by 91% and 86% following IFNG treatment, compared to untreated and carrier controls, respectively (both P < 0.01) (Figure 2A ). IL6 was reduced by 61% compared to the untreated control (P = 0.011), but the 44% reduction compared to carrier alone did not reach statistical significance ( Figure 2B ). CXCL1 was reduced by 67% compared to the untreated control (P = 0.003), and again the 55% reduction compared to carrier alone did not reach statistical significance with high variability in the data (P = 0.178) ( Figure 2C ).
IFNG inhibits TGFB-induced CSF2 production by mouse uterine epithelial cells in vitro
To investigate the molecular basis of IFNG suppression of seminal fluid-induced cytokine responses, we utilized mouse uterine epithelial cells in vitro. Expression of genes encoding IFNGR1 and IFNGR2 was confirmed by qPCR showing robust Ifngr1 and Ifngr2 mRNA (Supplemental Figure 1B) . TGFB is the key active factor in both mouse SP that elicits CSF2 production from uterine epithelial cells [25] . To investigate the effect of IFNG on basal and TGFB-stimulated cytokine production, uterine epithelial cells were incubated with combinations of TGFB1 (5 and 0.5 ng/ml) and IFNG (0.04-40 ng/ml) for 16 h. In supernatants collected 24 h later, CSF2, IL6, and CXCL1 content was measured by ELISA. As expected, TGFB1 induced CSF2 production with 2.2-and 3.1-fold increases elicited by 0.5 and 5 ng/ml TGFB1, respectively. IFNG alone resulted in substantial, dose-dependent inhibition of CSF2 secretion from concentrations as low as 0.16 ng/ml, with an 88% reduction in CSF2 output at 40 ng/ml (P = 0.005). IFNG added together with TGFB1 revealed interaction between these cytokines, with IFNG significantly downregulating CSF2 induced by 0.5 or 5 ng/mL TGFB, by up to 65% and 60%, respectively ( Figure 3A ) (P = 0.002 and P = 0.018). Seminal fluid contains three TGFB isoforms, with high concentrations of TGFB2 and TGFB3 as well as TGFB1. A preliminary experiment indicates that IFNG ex- Effects of treatments were analyzed using Kruskal-Wallis and Mann-Whitney U-test. * P < 0.05 compared to TGFB without IFNG; # P < 0.05 compared to media alone control.
erts suppressive activity against all three isoforms, with comparable effects on CSF2 induction by TGFB1, TGFB2, or TGFB3 (Supplemental Figure 2 ). Unlike CSF2, IL6 and CXCL1 production by mouse uterine epithelial cells were suppressed by 5 ng/ml TGFB1 (P = 0.001) and not changed by 0.5 ng/ml TGFB1. High concentrations of IFNG reversed the suppressive effect of TGFB on IL6 release, but no consistent effect of IFNG on IL6 or CXCL1 was seen ( Figure 3B and C). Individual symbols are mean values of triplicate wells for each of three experiments. Individual symbols are mean values of triplicate wells for each of three experiments and mean ± SEM is shown. Effects of treatments were analyzed by one-way ANOVA followed by Tukey's post hoc test. * P < 0.05, * * P < 0.01, compared to media alone control, # P < 0.05, compared to TGFB without IFNG.
IFNG perturbs TGFB-induced CSF2 production from human Ect1 cells
In human, as in mice, the major seminal fluid factor acting to induce CSF2 is TGFB [22] , and of the three TGFB isoforms in human SP, TGFB1 is the most abundant [22, [45] [46] [47] . Therefore, we added combinations of TGFB1 (50, 5, and 0.5 ng/ml) and IFNG (5 ng/ml) to Ect1 epithelial cells in vitro, to investigate whether IFNG operates in the human system to suppress CSF2 or other cytokines by interfering with TGFB signaling. As expected based on previous studies [22] , TGFB1 elicited increased CSF2 production by Ect1 cells in a dose-dependent manner with up to a 3.1-fold increase in mean values compared to mediaalone controls ( Figure 4A ). IFNG suppressed TGFB1-mediated induction of CSF2, with an interaction between TGFB and IFNG concentration such that IFNG was more inhibitory at low and moderate TGFB1 concentrations, causing a 66% reduction in CSF2 in cells exposed to 5.0 ng/ml TGFB1 (P < 0.0001). IFNG alone had minimal effect on CSF2 production ( Figure 4A) . Consistent with our previous findings [22] but in contrast to murine uterine epithelial cells, TGFB1 stimulated IL6 production in Ect1 cells, inducing increases up to 4.6-fold compared to the control (both P < 0.040) ( Figure 4B ). However, IFNG in combination with TGFB1 did not impact IL6 ( Figure 4B ). Conversely, TGFB1 at all doses moderately inhibited Ect1 cell production of CXCL8 ( Figure 4C ) and although IFNG attenuated this, the effect was minor ( Figure 4C ). IFNG alone did not alter production of IL6 Downloaded from https://academic.oup.com/biolreprod/article-abstract/99/3/514/4955550 by OUP site access user on 04 October 2018 FIGURE 5: Effect of IFNG on TGFB-mediated induction of CSF2 and IL6 gene expression by human Ect1 cells. Ect1 cells were cultured for 8 h with TGFB1 (0.5, 5.0, or 5 ng/ml), and/or IFNG (5 ng/ml), or medium alone then RNA was extracted for qPCR analysis. Panels are (A) CSF2 and (B) IL6 expression in arbitrary mRNA units calculated using the delta C(t) method and ACTB as housekeeping gene. Individual symbols are mean values of triplicate wells for each of three experiments and mean ± SEM are shown. Effects of treatments were analyzed by one-way ANOVA followed by Tukey's post hoc test.
* P < 0.05, * * P < 0.01, compared to media alone control, # P < 0.05, compared to TGFB without IFNG.
( Figure 4B ), but did exert a modest and consistent suppression of CXCL8 (P = 0.003) ( Figure 4C ). The effects of IFNG on Ect1 cytokine protein production were reflected in comparable changes in cytokine mRNA expression measured by qPCR 8 h after IFNG addition. This was most evident for CSF2 mRNA, where clear induction by TGFB and suppression of TGFB1-mediated induction was present ( Figure 5A ). However, IFNG did not consistently impact IL6 mRNA expression ( Figure 5B ).
IFNG perturbs TGFB-induced CSF2 production from human primary ectocervical cells
We next investigated whether IFNG inhibits TGFB-mediated CSF2 production in primary cervical epithelial cells. Ectocervical epithelial cells were recovered from hysterectomy tissue and incubated with combinations of TGFB1 (50, 5, and 0.5 ng/ml) and IFNG (5 ng/ml). Consistent with previous results [22] , TGFB1 increased CSF2 production by primary cervical epithelial cells in a dosedependent manner, with mean increases of up to 2.1-fold in cells from three different women (P < 0.001) ( Figure 4D ). Combinations of TGFB1 and IFNG again revealed interaction between the two molecules, with the strongest suppression by IFNG evident at the low and moderate doses of TGFB1 ( Figure 4D ).
TGFB1 also stimulated IL6 production in primary cells, with mean increases of up to 4.4-fold ( Figure 5B) . IFNG alone or in combination with TGFB1 had no effect on IL6 production ( Figure 4E) . No robust effect of TGFB1 on CXCL8 was seen, but IFNG inhibited CXCL8 production by 70% (P < 0.001). Similar inhibition was seen when IFNG was added in combination with TGFB1 ( Figure 5C ).
Reciprocal interactions between TGFB and IFNG on cytokine receptor expression in Ect1 cells
To investigate the mechanisms by which IFNG and TGFB differentially regulate CSF2 production, we lastly measured the effect of IFNG and TGFB on expression of their respective receptor genes 8 h after addition to Ect1 cells. Mixed model analysis showed that IFNG moderately suppressed expression of TGFBR2 (P < 0.001) but not TGFBR1 (Figure 6A and B) . TGFB1 independently suppressed TGFBR2 and moderately elevated TGFBR1 (both P < 0.05) (Figure 6A and B) . Conversely, TGFB1 inhibited both IFNGR1 and IFNGR2 (both P < 0.001), while IFNG had little effect ( Figure 6C and D). Moderate and high doses of 5 and 50 ng/ml TGFB1 suppressed both IFNGR1 and IFNGR2 by nearly 50% compared to media alone control (both P < 0.001) ( Figure 6C and D) .
Discussion
Seminal plasma IFNG is generally undetectable or present at very low, biologically irrelevant levels in normal fertile men [27, 29, 48] , but can be moderately elevated in men with sperm abnormalities, idiopathic infertility and in the partners of women experiencing recurrent miscarriage [26, 28, 34, 35] . Substantially, higher IFNG is present in men with overt reproductive tract infection [32, 33] . The current study indicates a clear inhibitory impact of IFNG on SP induction of cytokines from both human cervical epithelial cells and mouse uterine epithelial cells (Table 2) , implying the conservation of this interaction across mammalian species. Notably, IFNG potently and consistently suppressed seminal fluid TGFB-mediated induction of CSF2, a key cytokine required for normal female immune adaptation to pregnancy. A mutually antagonistic interaction between IFNG and TGFB in regulating synthesis of CSF2 was seen in both mouse and human cells. In mice, IFNG inhibited CSF2 induction by seminal fluid both in vitro and in vivo, adding confidence that the in vitro culture models reflect physiological effects in vivo.
The concentrations of IFNG evaluated in this study approximate IFNG levels present in men with clinical conditions. In oligozoospermic and azoospermic men, SP IFNG is reported to be 30-220 pg/ml [26, 28] . A study of 55 Polish couples with idiopathic infertility reported seminal fluid IFNG to be moderately elevated at median (range) values of 80 (48-110) pg/ml, compared with 60 (8-90) pg/ml in 27 fertile controls. In normospermic men without overt infection, we found IFNG to fluctuate over time from <1 to 10 pg/ml [48] , while others report ranges of <3 to 130 pg/ml in larger population samples [26, 29, 34] . Thus, the lower concentration of 50 pg/ml, which clearly suppressed CSF2 in two out of three human seminal fluid samples, is clearly within the range reported for infertile men, and likely also present in some overtly normal, fertile men. A more than 1000-fold higher IFNG level of up to 250 ng/ml has been reported in Madagascan men with Schistosomiasis haematobium [32] , while HIV induces a more than 30-fold increase compared with seronegative men [33] . The higher concentration of 5 ng/ml tested herein, which suppressed CSF2 synthesis in all of three FIGURE 6: Effect of IFNG and TGFB1 on cytokine receptor gene expression in human Ect1 cells. Ect1 cells were cultured for 8 h with TGFB1 (0.5, 5.0, or 5 ng/ml), and/or IFNG (5 ng/ml), or medium alone then RNA was extracted for qPCR analysis. Panels are (A) TGFBR1, (B) TGFBR2, (C) IFNGR1, and (D) IFNGR2 expression in arbitrary mRNA units calculated using the delta C(t) method and ACTB as housekeeping gene. Individual symbols are mean values of triplicate wells for each of three experiments and mean ± SEM are shown. Effects of treatments were analyzed by one-way ANOVA followed by Tukey's post hoc test, and by mixed model analysis.
* P < 0.05, * * P < 0.01, compared to media alone control, # P < 0.05, compared to TGFB without IFNG. Mixed model analysis shows TGFBR1 is regulated by TGFB1 (P = 0.012); TGFBR2 is regulated by IFNG (P = 0.001) and TGFB1 (P = 0.033); IFNGR1 is regulated by TGFB1 (P < 0.001) and IFNG (P = 0.001), and IFNGR2 is regulated by TGFB1 (P = 0.012). human seminal fluid samples, is therefore representative of seminal fluid content of men with HIV and presumably other infections that invoke a cell-mediated immune response in the male reproductive tract, although IFNG may be differentially elevated in men depending on the specific infectious pathogen. IFNG is also detected in the seminal fluid of healthy mice, with an average level of ∼50 pg/ml [49] , but whether this increases after male reproductive tract infection has not been studied. presumably contributes to the protection from IFNG conferred by greater TGFB bioavailability.
There have been no previous reports of effects of IFNG on reproductive tract epithelial cells, other than one study showing that IFNG instilled into the uterine lumen of rats can promote secretion of immunoglobulin A and secretory component, in a response attenuated by estrogen [50] . IFNG acts in other cell types to directly interfere with TGFB signaling. In retinal pigment epithelial cells, TGFB1 causes induction of CSF2 synthesis and this is potently suppressed by IFNG [51] . Antagonistic interactions between TGFB and IFNG are also seen in human monocytes, where IFNG inhibits TGFB1-induced integrin-α5 expression and adhesion to fibronectin and laminin [52] . As reported for other cell lineages [52] , we found that TGFB and IFNG regulation of CSF2 regulation occurs largely at the transcriptional level, although modification of CSF2 mRNA stability likely also contributes [53] .
In other cell lineages, IFNG inhibits TGFB signaling after the IFNG signal transducer STAT1 induces expression of the TGFB inhibitory molecule SMAD7, which forms stable associations with TGFBRI and TGFBRII to suppress signal transduction [54] and counteract the activating SMADs induced by TGFBR ligation [55, 56] . In lung fibroblasts, IFNG potently suppresses TGFB-induced collagen deposition via STAT1-dependent signaling and cross-talk with the TGFB-induced SMAD signaling pathway [57, 58] . In human hepatoma Hep3B cells and gastric carcinoma cells, IFNG-induced SMAD7 expression interferes with TGFB-induced SMAD2/3 phosphorylation and nuclear translocation, inhibiting functional SMAD-DNA complex formation [59, 60] . A mechanism involving failure to initiate SMAD-mediated effects on CSF2 gene transcription is consistent with our finding of reduced CSF2 mRNA in the presence of IFNG, acting in synergy with reduced TGFBR1 and TGFBR2 bioavailability.
A reciprocal interaction between TGFB and IFNG signaling in female tract epithelial cells thus has the ability to modulate TGFBinduced CSF2 synthesis, in response to the relative abundance of TGFB and IFNG delivered in SP at coitus. Since IFNG suppresses the response to TGFB2 and TGFB3 as well as TGFB1, and all three TGFB isoforms as well as IFNG fluctuate in seminal fluid even in fertile men [24, 48] , there is substantial potential for considerable variation in seminal fluid capacity to induce CSF2 in female tract epithelial cells. This is consistent with the variation between fertile men in capacity to induce CSF2 within Ect1 cells that we reported previously [61] .
Other cytokines shown previously to be induced by SP, including CXCL8 in human [17] , and IL6 and CXCL1 in mouse [3] , were modulated to a lesser degree and through mechanisms that do not appear to involve suppression of TGFB signaling (Table 2) . Notably, IFNG interfered with SP induction of IL6 in human cervical epithelial cells, and although TGFB is consistently found to contribute to IL6 induction it does not fully account for the IL6 response [22] and so the means by which IFNG interferes remains to be defined. Similarly, IFNG reduced IL6 production in mice in vivo, but factors other than TGFB may account for IL6 induction in mice, since TGFB did not induce IL6 in vitro.
CXCL8 and its mouse homologue CXCL1 were also inhibited by IFNG, particularly in human primary ectocervical cells where, as previously reported, production is higher than in Ect1 cells [61] . This effect was largely overcome by the presence of CXCL8-inducing agents in SP. A similar inhibitory effect of IFNG on CXCL8 production occurs in human polymorphonuclear cells [62] . The differential effects of IFNG on cytokines induced by factors other than TGFB in SP suggest complexity in mechanism beyond solely inhibition of TGFB signaling. In contrast, we found that other cytokines induced in human ectocervical cells by SP, notably CCL2 (MCP1) [22, 61] , were completely unaltered by IFNG (data not shown). A differential impact of IFNG on different female tract cytokines is likely to be physiologically relevant as an altered cytokine balance has the potential to skew the phenotypes of immune cells in the conception environment, and therefore influence whether or not immune tolerance is generated.
The particular sensitivity of CSF2 to IFNG is interesting given its key role as a permissive cytokine in promoting fertility. The major targets for CSF2 action in the reproductive tissues are immune cells, both in women and in mice. The consequence of reduced CSF2 expression after seminal fluid contact in mice is reduced recruitment of macrophages and dendritic cells [9] , and altered activation phenotypes in those cells, as demonstrated in Csf2 null mutant mice [5] . In turn, this impairs priming of T cells reactive with paternal seminal fluid antigens [5] , that would interfere with generation of the uterine Treg cell population required for maternal immune tolerance at embryo implantation [63, 64] . Previous studies have shown that intravaginal administration of IFNG in early pregnancy in mice causes implantation failure through suppression of Treg cells and elevated generation of Th1 immunity [65] .
Whether reduced CSF2 induction secondary to elevated IFNG in the cervix after coitus similarly affects the immune adaptation favoring pregnancy in women is not yet clear. Human seminal fluid promotes Treg cell generation and immune regulatory function to mediate female immune tolerance to male transplantation antigens [66, 67] and this presumably contributes to the accumulation of decidual Treg cells in early pregnancy [68] . As well as through CSF2, TGFB in seminal fluid directly influences generation of Treg cells through promoting a protolerance phenotype in uterine antigenpresenting cells [69] . An extensive body of evidence shows that IFNG has potent immune proinflammatory and immune-regulatory functions, through its activation of macrophages to promote IL12 and TNF release, and skewing the adaptive immune response towards T helper type 1 (Th1) instead of Th2 and Treg cell generation [30, 31] . If seminal fluid IFNG acts to interfere with the innate and adaptive immune response at conception, this could adversely impact reproductive events downstream of implantation, as has been shown in mouse studies when the periconception T cell response is skewed away from Treg cells and towards effector immunity [70, 71] .
Additionally, CSF2 deficiency inhibits development of preimplantation embryos, which depend on maternal tract-derived CSF2 support to prevent cell stress and apoptosis, and promote optimal implantation competence [72] . In vitro studies show a comparable influence of CSF2 on human blastocyst development [12, 73] . Women with CSF2 deficiency in reproductive tissues are reported to have higher rates of unexplained infertility and miscarriage [74] , while assisted reproduction treatments that involve supplementing embryo culture media with CSF2 can improve IVF outcomes [75] . Suppressed CSF2 secondary to elevated seminal fluid IFNG could feasibly interfere with normal blastocyst development.
In summary, this study identifies IFNG as a physiologically relevant inhibitor of the female tract response to seminal fluid after coitus in mice, and indicates strong evidence of a similar response in women. IFNG acts to potently suppress seminal fluid TGFBmediated induction of CSF2, a key cytokine required for female immune adaptation for pregnancy. Since IFNG can be elevated in the SP of men with reduced fertility, even in conditions where there is no demonstrable impairment in sperm parameters, this may provide a new pathophysiological mechanism contributing to some forms of idiopathic male infertility and subfertility. The high sensitivity of CSF2 and the consistent differential impact on this cytokine as opposed to other female tract cytokines induced by seminal fluid suggests a central role for CSF2 in female sensing and responding to seminal fluid quality. This would have biological and evolutionary utility in reducing the likelihood of pregnancy in the case of male reproductive tract infection, or other inflammatory disturbances that increase seminal fluid IFNG content. Elevated IFNG due to local synthesis in the female reproductive tract, for example in the event of sexually transmitted infection [76] , could also adversely impact seminal fluid-mediated induction of CSF2 in the conception phase. Further research will be required to identify the clinical factors and regulatory mechanisms that cause elevated IFNG, and to more fully determine their relationship with fertility status in men and women.
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Supplemental Figure 1 . Quantitative PCR analysis of IFNG receptor expression. Quantitative PCR was performed on cDNA generated from untreated (A) human Ect1 ectocevical epithelial cells and (B) mouse uterine epithelial cells using oligonucleotides specific for mRNA encoding the IFNG receptors IFNGR1 and IFNGR2 (human) and Ifngr1 and Ifngr2 (mouse). PCR products were electrophoresed on a 2% agarose gel, together with 1 kb plus DNA ladder and house-keeping gene ACTB (Actb; mouse) and photographed. Supplemental Figure 2 . Effect of IFNG on induction of CSF2 by TGFB1, TGFB2, and TGFB in mouse uterine epithelial cells in vitro.
Epithelial cells were cultured with TGFB1, TGFB2, or TGFB3 [( r ) 0 ng/ml, ( ) 0.5 ng/ml or ( ) 5 ng/ml], and/or IFNG (0.01-160 ng/ml). Supernatants were collected 12 h following removal of treatments and analyzed for CSF2 content by ELISA. Panels are effects of IFNG on CSF2 response to (A) TGFB1, (B) TGFB2, and (C) TGFB3, shown as mean CSF2 output in pg/10 5 cells of duplicate wells for each treatment. Data were normalized to the number of viable uterine epithelial cells at the end of the culture period. Mixed model analysis shows CSF2 is regulated by IFNG, TGFB1, TGFB2, and TGFB3 (all P < 0.001), and IFNG interacts with all three TGFB isoforms to suppress the CSF2 response (all P < 0.01).
